✦ LIBER ✦

Definition of treatment goals for moderate to severe psoriasis: a European consensus

✍ Scribed by U. Mrowietz; K. Kragballe; K. Reich; P. Spuls; C. E. M. Griffiths; A. Nast; J. Franke; C. Antoniou; P. Arenberger; F. Balieva; M. Bylaite; O. Correia; E. Daudén; P. Gisondi; L. Iversen; L. Kemény; M. Lahfa; T. Nijsten; T. Rantanen; A. Reich; T. Rosenbach; S. Segaert; C. Smith; T. Talme; B. Volc-Platzer; N. Yawalkar

Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 311 KB
Volume: 303
Category: Article
ISSN: 0340-3696
DOI: 10.1007/s00403-010-1080-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Strategies for optimizing treatment with

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis

✍ Kim A. Papp; Vincent Ho; Richard Langley; Charles Lynde; Yves Poulin; Neil Shear 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 155 KB

Integrating Biologic Agents into Managem

Integrating Biologic Agents into Management of Moderate-to-Severe Psoriasis: A Consensus of the Canadian Psoriasis Expert Panel

✍ Lyn Guenther; Richard G. Langley; Neil H. Shear; Robert Bissonnette; Vincent Ho; 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 209 KB

Recommendations for incorporating biolog

Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches

✍ Richard G. Langley; Vincent Ho; Charles Lynde; Kim A. Papp; Yves Poulin; Neil Sh 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 98 KB

Protocols for the initial treatment of m

Protocols for the initial treatment of moderately severe juvenile dermatomyositis: Results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference

✍ Adam M. Huber; Edward H. Giannini; Suzanne L. Bowyer; Susan Kim; Bianca Lang; Ca 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 161 KB 👁 2 views

The effect of folic acid supplementation

The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis

✍ Jaroslav Chládek; Marie Simková; Jaroslava Vanecková; Milos Hroch; Jirina Chládk 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 203 KB

Adalimumab for the treatment of patients

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial

✍ Philip J. Mease; Dafna D. Gladman; Christopher T. Ritchlin; Eric M. Ruderman; Se 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views